We are live on ! Find out more
INBX

Inhibrx, Inc. Common Stock
INBX

Delisted

INBX was delisted on the 29th of May, 2024.

Back to rankings

2 hedge funds and large institutions have $1.16M invested in Inhibrx, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 123 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less funds holding

Funds holding: 126 → 2 (-124)

100% less capital invested

Capital invested by funds: $1.34B → $1.16M (-$1.34B)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 123

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-124
Holders Change %
-98.41%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
123
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Viking Global Investors
Viking Global Investors
Connecticut
-$250M
2
PA
Perceptive Advisors
New York
-$149M
3
BlackRock
BlackRock
New York
-$96.2M
4
RCM
RA Capital Management
Massachusetts
-$91.9M
5
State Street
State Street
Massachusetts
-$84.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
– -$10.8M -307,541 Closed
Barclays
27
Barclays
United Kingdom
– -$9.87M -282,303 Closed
Two Sigma Advisers
28
Two Sigma Advisers
New York
– -$9.86M -282,000 Closed
SCM
29
Soleus Capital Management
Connecticut
– -$9.36M -267,871 Closed
WCMNY
30
Westchester Capital Management (New York)
New York
– -$9M -257,368 Closed
Charles Schwab
31
Charles Schwab
California
– -$8.09M -231,434 Closed
Rafferty Asset Management
32
Rafferty Asset Management
New York
– -$7.06M -201,948 Closed
Russell Investments Group
33
Russell Investments Group
United Kingdom
– -$6.66M -190,389 Closed
PIM
34
Platinum Investment Management
Australia
– -$5.1M -145,966 Closed
CF
35
Cantor Fitzgerald
New York
– -$4.88M -139,715 Closed
HighTower Advisors
36
HighTower Advisors
Illinois
– -$4.61M -131,900 Closed
LNWWM
37
Laird Norton Wetherby Wealth Management
California
– -$4.58M -131,023 Closed
Wellington Management Group
38
Wellington Management Group
Massachusetts
– -$4.55M -130,044 Closed
Bank of New York Mellon
39
Bank of New York Mellon
New York
– -$3.79M -108,369 Closed
MWA
40
Meridian Wealth Advisors
Texas
– -$3.5M -100,000 Closed
AA
41
AQR Arbitrage
Connecticut
– -$3.42M -97,774 Closed
N
42
Nuveen
North Carolina
– -$2.9M -82,829 Closed
Two Sigma Investments
43
Two Sigma Investments
New York
– -$2.74M -78,400 Closed
JP Morgan Chase
44
JP Morgan Chase
New York
– -$2.54M -72,764 Closed
CM
45
Caption Management
Oklahoma
– -$2.28M -65,287 Closed
Susquehanna International Group
46
Susquehanna International Group
Pennsylvania
– -$2.23M -63,710 Closed
Ensign Peak Advisors
47
Ensign Peak Advisors
Utah
– -$1.96M -56,173 Closed
Deutsche Bank
48
Deutsche Bank
Germany
– -$1.92M -54,804 Closed
YCM
49
Yakira Capital Management
Connecticut
– -$1.88M -53,762 Closed
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
– -$1.8M -51,485 Closed
1
2
3 4 5

INBX Hedge Fund Activity: Q2 2024 in Review

2 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q2 2024, worth a combined $1.16M — down 100% from $1.34B a quarter earlier.

Sellers outnumbered buyers: 123 funds closed out of INBX and 0 opened new positions — a net loss of 123 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Viking Global Investors, exiting entirely with an estimated $250M sold.

  • 2 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q2 2024, down from 126 in Q1 2024.
  • Funds reported $1.16M of Inhibrx, Inc. Common Stock stock for Q2 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Inhibrx, Inc. Common Stock positions in Q2 2024 and 123 closed out, a net change of -123 holders.
  • The largest Inhibrx, Inc. Common Stock seller in Q2 2024 was Viking Global Investors, an estimated $250M sold.

Based on aggregated 13F filings for Q2 2024.